New directions in the coordination chemistry of 99mTc:: a reflection on technetium core structures and a strategy for new chelate design

被引:161
作者
Banerjee, SR
Maresca, KP
Francesconi, L
Valliant, J
Babich, JW
Zubieta, J [1 ]
机构
[1] Syracuse Univ, Ctr Sci & Technol, Dept Chem, Syracuse, NY 13244 USA
[2] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA
[3] McMaster Univ, Dept Chem, Hamilton, ON L8S 4M1, Canada
[4] Mol Insight Pharmaceut Inc, Cambridge, MA 02142 USA
关键词
Tc-99m imaging agents; HYNIC; MAG(3); single amino acid chelates (SAAC); {Tc(CO)(3)}(1+) core;
D O I
10.1016/j.nucmedbio.2004.09.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Bifunctional chelates offer a general approach for the linking of radioactive metal cations to macromolecules. In the specific case of Tc-99m, a variety of technologies have been developed for assembling a metal-chelate-biomolecule complex. An evaluation of these methodologies requires an appreciation of the coordination characteristics and preferences of the technetium core structures and oxidation states, which serve as platforms for the development of the imaging agent. Three technologies, namely, the MAG(3)-based bifunctional chelates, the N-oxysuccinimidylhydrazino-nicotinamide system and the recently described single amino acid chelates for the {Tc(CO)(3)}(1+) core, are discussed in terms of the fundamental coordination chemistry of the technetium core structures. In assessing the advantages and disadvantages of these technologies, we conclude that the single amino acid analogue chelates (SAAC), which are readily conjugated to small peptides by solid-phase synthesis methods and which form robust complexes with the {Tc(CO)(3)}(1+) core, offer an effective alternative to the previously described methods. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 20
页数:20
相关论文
共 186 条
[71]  
GOODBODY A, 1995, PCT INT APPL
[72]   Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-ε-(Hynic-Boc)-Lysine, a technetium-binding amino acid:: Application to Tc-99m-labeled salmon calcitonin [J].
Greenland, WEP ;
Howland, K ;
Hardy, J ;
Fogelman, I ;
Blower, PJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (09) :1751-1757
[73]   Nature of cysteine-based Re(V)=O(N2S2) radiopharmaceuticals at physiological pH ascertained by investigation of a new complex with a meso N2S2 ligand having carboxyl groups anti to the oxo group [J].
Hansen, L ;
Hirota, S ;
Xu, XL ;
Taylor, AT ;
Marzilli, LG .
INORGANIC CHEMISTRY, 2000, 39 (25) :5731-5740
[74]   Group 7 'organohydrazide' chemistry: classification of ligand type based on crystal structural data [J].
HirschKuchma, M ;
Nicholson, T ;
Davison, A ;
Jones, AG .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1997, (18) :3189-3192
[75]  
HNATOWICH DJ, 1993, J NUCL MED, V34, P109
[76]   Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine [J].
Hoepping, A ;
Babich, J ;
Zubieta, JA ;
Johnson, KM ;
Machill, S ;
Kozikowski, AP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (22) :3211-3216
[77]   Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells [J].
Hoffman, TJ ;
Quinn, TP ;
Volkert, WA .
NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (05) :527-539
[78]   Heterodimeric bis(amino thiol) complexes of oxorhenium(V) that mimic the structure of steroid hormones. Synthesis and stereochemical issues [J].
Hom, RK ;
Chi, DY ;
Katzenellenbogen, JA .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (08) :2624-2631
[79]   Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging results [J].
Hom, RK ;
Katzenellenbogen, JA .
NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (06) :485-498
[80]   CHEMOTAXIS [J].
HUGLI, TE .
CURRENT OPINION IN IMMUNOLOGY, 1989, 2 (01) :19-27